tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DocMorris Completes Convertible Bonds Repurchase Offer
Company AnnouncementsDocMorris Completes Convertible Bonds Repurchase Offer
2M ago
DocMorris Initiates Buyback Offer for 2026 Convertible Bonds
PremiumCompany Announcements
DocMorris Initiates Buyback Offer for 2026 Convertible Bonds
2M ago
DocMorris Completes CHF 49.6 Million Convertible Bond Issuance
PremiumCompany Announcements
DocMorris Completes CHF 49.6 Million Convertible Bond Issuance
3M ago
DocMorris Launches CHF 45 Million Convertible Bond for Strategic Repurchase
PremiumCompany Announcements
DocMorris Launches CHF 45 Million Convertible Bond for Strategic Repurchase
3M ago
Positive Growth Trends and Strategic Outlook Justify Buy Rating for DocMorris
PremiumRatings
Positive Growth Trends and Strategic Outlook Justify Buy Rating for DocMorris
3M ago
DocMorris Reports Strong Revenue Growth and Strategic AI Expansion
PremiumCompany AnnouncementsDocMorris Reports Strong Revenue Growth and Strategic AI Expansion
3M ago
DocMorris: Strategic Growth and Innovation Drive Buy Recommendation
Premium
Ratings
DocMorris: Strategic Growth and Innovation Drive Buy Recommendation
4M ago
Zur Rose Group AG: Earnings Call Highlights Growth and Innovation
Premium
Company Announcements
Zur Rose Group AG: Earnings Call Highlights Growth and Innovation
4M ago
DocMorris: Balancing Challenges and Growth Opportunities with a Buy Rating
PremiumRatings
DocMorris: Balancing Challenges and Growth Opportunities with a Buy Rating
5M ago
DocMorris Boosts Rx Sales and Expands Digital Health Ecosystem
PremiumCompany Announcements
DocMorris Boosts Rx Sales and Expands Digital Health Ecosystem
5M ago
DocMorris Reintroduces Prescription Bonuses Following BGH Ruling
PremiumCompany Announcements
DocMorris Reintroduces Prescription Bonuses Following BGH Ruling
6M ago
DocMorris Secures CardLink Approval Extension to 2027
PremiumCompany Announcements
DocMorris Secures CardLink Approval Extension to 2027
6M ago
DocMorris AG Completes Successful Rights Offering
PremiumCompany AnnouncementsDocMorris AG Completes Successful Rights Offering
8M ago
Pelion Acquires Significant Stake in DocMorris
Premium
Company Announcements
Pelion Acquires Significant Stake in DocMorris
8M ago
DocMorris AG Shareholders Approve CHF 200 Million Capital Increase
Premium
Company Announcements
DocMorris AG Shareholders Approve CHF 200 Million Capital Increase
8M ago
DocMorris Announces CHF 200 Million Capital Increase to Boost Growth
PremiumCompany Announcements
DocMorris Announces CHF 200 Million Capital Increase to Boost Growth
8M ago
DocMorris’s Promising Growth and Strategic Financial Maneuvers Earn a Buy Rating
PremiumRatings
DocMorris’s Promising Growth and Strategic Financial Maneuvers Earn a Buy Rating
9M ago
DocMorris: Buy Rating Affirmed Amid Capital Raise and Strategic Growth Plans
PremiumRatings
DocMorris: Buy Rating Affirmed Amid Capital Raise and Strategic Growth Plans
9M ago
DocMorris Secures CHF 200 Million for Strategic Growth
PremiumCompany Announcements
DocMorris Secures CHF 200 Million for Strategic Growth
9M ago
DocMorris’s Strategic Growth and Market Positioning Justify Buy Rating
PremiumRatingsDocMorris’s Strategic Growth and Market Positioning Justify Buy Rating
9M ago
Zur Rose Group AG: Cautious Optimism in Earnings Call
Premium
Company Announcements
Zur Rose Group AG: Cautious Optimism in Earnings Call
10M ago
DocMorris Faces Uncertainty Amid Planned Capital Increase and Competitive Challenges
Premium
Ratings
DocMorris Faces Uncertainty Amid Planned Capital Increase and Competitive Challenges
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >